In Canada, the legal production and sale of marijuana is regulated under The Cannabis Act. To comply with the law, cannabis producers must receive regulatory approval for commercial growing and... read more →
Even before Aleafia Health (TSX: ALEF) (OTCQX: ALEAF) (FRA: ARAH) acquired Emblem it was worth $6.50 according to Mackie Research. It seems that the market is adjusting to the newly-formed... read more →
Gone are the days where cannabis of questionable quality was bought from less than savoury drug dealers in shadowy places. The modern cannabis industry is quickly evolving into a polished,... read more →
If there is one primary marker of the maturity of the cannabis industry, it is the rise of the mundane. Nevertheless, companies that take advantage of the day-to-day needs of... read more →
Of Mice and Men and Cannabis Companies Cannabis supply troubles continue in Canada due to a variety of factors. In the spring of 2019 and into summer, companies face a... read more →
Michigan’s Medical Marijuana market is off to a hot start, racking in over $42 million in revenue in just its first 4 months of business. Dispensaries officially opened for business... read more →
Aleafia Health Patient Outcomes Point to Potential Pivot from Opioids and Benzos towards Medical Cannabis—a potential $25 Billion shift Heading into the last week of January, vertically integrated Canadian medicinal... read more →
The California cannabis industry ecosystem is in a state of complete disarray. An industry that has been projected to generate more than $6.5 billion (Arcview Market Research) in revenue by... read more →
News broke recently of a tie-up that shows the medical cannabis industry in a new light: it is a market where more mature players both gain opportunity and give it... read more →
The month of January has historically been a great month for Cannabis stocks and the stock market as a whole. After a brutal finish to 2018 caused by tax loss... read more →
